Yucel Yilmaz
Overview
Explore the profile of Yucel Yilmaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serhatlioglu F, Cetinkaya Z, Yilmaz Y
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597855
Recently, a new inflammatory and prognostic marker called glucose/lymphocyte ratio (GLR) has been used in patients with coronary artery disease. In this study, we analyzed the correlation between GLR and...
2.
Serhatlioglu F, Cetinkaya Z, Yilmaz Y
J Cardiovasc Dev Dis
. 2024 Nov;
11(11).
PMID: 39590180
Coronary artery bypass grafting (CABG) remains the gold standard treatment for patients with significant coronary artery disease (CAD) and high-risk profiles for percutaneous coronary intervention. Despite the frequent use of...
3.
Yilmaz Y, Kelesoglu S
Angiology
. 2024 Jun;
:33197241258529.
PMID: 38822733
In this study, the correlation between pan-immune-inflammation value (PIV) and coronary collateral circulation (CCC) in patients with chronic coronary syndrome (CCS) was analyzed. The study included 663 patients with CCS...
4.
Kelesoglu S, Yilmaz Y, Elcik D, Tuncay A, Bireciklioglu F, Balci M, et al.
Angiology
. 2024 Apr;
:33197241247576.
PMID: 38626988
No abstract available.
5.
Cetinkaya Z, Kelesoglu S, Tuncay A, Yilmaz Y, Karaca Y, Karasu M, et al.
J Clin Med
. 2024 Apr;
13(5).
PMID: 38592192
Background: Even though medication and interventional therapy have improved the death rate for non-ST elevation myocardial infarction (NSTEMI) patients, these patients still have a substantial residual risk of cardiovascular events....
6.
Ergun G, Tanriverdi H, Demirci E, Dogan Y, Yilmaz Y, Kelesoglu S, et al.
Turk Kardiyol Dern Ars
. 2024 Mar;
52(2):110-115.
PMID: 38465532
Objective: The metabolic equivalent (MET) and Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) score are two parameters with known cardiovascular prognostic significance. In this study, we...
7.
Kelesoglu S, Yilmaz Y, Elcik D, Bireciklioglu M, Ozdemir F, Balci F, et al.
Angiology
. 2023 Dec;
:33197231216205.
PMID: 38087475
No abstract available.
8.
Dogan Y, Yilmaz Y, Kelesoglu S, Calapkorur B, Neselioglu S, Erel O, et al.
J Clin Med
. 2023 Oct;
12(19).
PMID: 37835005
Our aim was to investigate the relationship between thiol, which is the main component of the antioxidant system, and coronary collateral circulation (CCC). Our patients consisted of people with stable...
9.
Kelesoglu S, Yilmaz Y, Elcik D, Bireciklioglu F, Ozdemir F, Balci F, et al.
Angiology
. 2022 Dec;
74(8):790-797.
PMID: 36475400
Stroke is a significant contributor to morbidity and mortality. The present study investigated how the systemic immune inflammation index (SII) could be used to predict the likelihood of developing carotid...
10.
Kelesoglu S, Yilmaz Y, Elcik D, Tuncay A, Bireciklioglu F, Balci M, et al.
Angiology
. 2022 Nov;
75(1):90-97.
PMID: 36369651
This study evaluated the role of the C-reactive protein (CRP)/albumin ratio (CAR) in estimating the probability of occurring contrast-induced nephropathy (CIN) after carotid artery angiography (CAAG). Patients (n = 410)...